169 related articles for article (PubMed ID: 10845912)
1. Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation.
Ajzenberg N; Ribba AS; Rastegar-Lari G; Meyer D; Baruch D
Blood; 2000 Jun; 95(12):3796-803. PubMed ID: 10845912
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
3. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
4. Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of alpha IIb beta 3 engagement.
Mekrache M; Bachelot-Loza C; Ajzenberg N; Saci A; Legendre P; Baruch D
Blood; 2003 Jun; 101(11):4363-71. PubMed ID: 12543870
[TBL] [Abstract][Full Text] [Related]
5. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
J Thromb Haemost; 2007 Feb; 5(2):282-8. PubMed ID: 17155947
[TBL] [Abstract][Full Text] [Related]
7. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
[TBL] [Abstract][Full Text] [Related]
8. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.
Depraetere H; Ajzenberg N; Girma JP; Lacombe C; Meyer D; Deckmyn H; Baruch D
Blood; 1998 May; 91(10):3792-9. PubMed ID: 9573016
[TBL] [Abstract][Full Text] [Related]
10. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF.
Hilbert L; Gaucher C; Mazurier C
Blood; 1995 Aug; 86(3):1010-8. PubMed ID: 7620154
[TBL] [Abstract][Full Text] [Related]
11. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor.
Christophe O; Ribba AS; Baruch D; Obert B; Rouault C; Niinomi K; Piétu G; Meyer D; Girma JP
Blood; 1994 Jun; 83(12):3553-61. PubMed ID: 8204881
[TBL] [Abstract][Full Text] [Related]
12. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.
Rayes J; Hommais A; Legendre P; Tout H; Veyradier A; Obert B; Ribba AS; Girma JP
J Thromb Haemost; 2007 Feb; 5(2):321-8. PubMed ID: 17087728
[TBL] [Abstract][Full Text] [Related]
13. Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factor.
Hilbert L; Gaucher C; Mazurier C
Br J Haematol; 1995 Dec; 91(4):983-90. PubMed ID: 8547152
[TBL] [Abstract][Full Text] [Related]
14. The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13.
Ma Z; Su J; Zhang J; Ling J; Yin J; Bai X; Ruan C
Thromb Res; 2015 Nov; 136(5):987-95. PubMed ID: 26345337
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets.
Cooney KA; Ginsburg D
Blood; 1996 Mar; 87(6):2322-8. PubMed ID: 8630394
[TBL] [Abstract][Full Text] [Related]
16. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
18. Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578Leu.
Hilbert L; Gaucher C; Abgrall JF; Parquet A; Trzeciak C; Mazurier C
Br J Haematol; 1998 Dec; 103(3):877-84. PubMed ID: 9858249
[TBL] [Abstract][Full Text] [Related]
19. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
Jenkins PV; Pasi KJ; Perkins SJ
Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
